Biocon Limited has informed the Exchange regarding Notice of Postal Ballot
BIOCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biocon Limited has issued a Postal Ballot Notice dated May 2, 2025, seeking shareholder approval through e-voting (from May 6 to June 4, 2025; results by June 6, 2025). The first resolution seeks to increase the Authorised Share Capital from Rs. 625 Crores to Rs. 700 Crores by adding 15 crore new equity shares of Rs. 5 each. The second, more material resolution, seeks approval to raise up to Rs. 4,500 Crores through the issuance of equity shares and/or other securities via Qualified Institutions Placement (QIP), rights issue, preferential allotment, or private placement, in one or more tranches. The funds will primarily be used to prepay/repay outstanding borrowings, fulfil financial commitments and debt obligations of the Company and its subsidiary Biocon Biologics Limited (BBL) — including purchasing, redeeming, or restructuring BBL's debt instruments — and to invest in subsidiaries or for general corporate purposes.
This is a significant equity dilution event: a potential capital raise of up to Rs. 4,500 Crores could meaningfully expand the share count and pressure the stock price near issuance, depending on pricing and demand. However, deleveraging the balance sheet (especially BBL's debt) is viewed positively by long-term investors as it strengthens the parent company's financial position.